JPRN-UMIN000014012已完成未知
Japan Trial in High-risk Individuals to Accelerate their Referral to Physicians: A Nurse-led, Community-based Prevention Program of Lifestyle-related Disease - J-HARP
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 18,400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Having difficulty in receiving health guidance due to cognitive impairments, other psychiatric disorders, hearing and visual impairments, and other reasons.
研究者
相似试验
已完成
不适用
Pilot Trial against High-risk Individuals to support their visits to the attending physicians: A Occupational physicians or nurse-led, Workplace-based Prevention Program of Lifestyle-related DiseaseHypertension, diabetes mellitus, and/or dyslipidemiaJPRN-UMIN000021577Juntendo University100
已完成
不适用
Japan-multimodal intervention Trial for prevention of dementia (J-MINT) in KanagawaJPRN-UMIN000041887Yokohama City University240
已完成
不适用
Japan-multimodal intervention Trial for prevention of dementia (J-MINT)Older adults with cognitive impairment.JPRN-UMIN000038671ational Center for Geriatrics and Gerontology531
尚未招募
不适用
The Benzodiazepine Agent Tapering Trial in Japamental diseaseJPRN-UMIN000017765ational Center of Neurology and Psychiatry20
进行中（未招募）
1 期
International Trial for Patients with High Risk MedulloblastomaHistologically proven high-risk medulloblastoma, with any of the currently defined histological subtypes. High-risk disease is defined as patients with sonic hedgehog (SHH) subgroup or non-SHH/non-wingless-type (WNT) (Groups 3 and 4) medulloblastoma, with at least one additional high risk featureMedDRA version: 20.0Level: PTClassification code 10027107Term: MedulloblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-004250-17-NLniversity of Birmingham850